Wellspect Norway

Aktuelle artikler

It's time to stop ignoring major patient groups

Publisert av Wellspect Norway, 20.mai.2022

For a successful therapy, it’s important to find out the patients’ actual experiences when performing intermittent catheterization (IC). But a lack of research can provide obstacles. Have we heard directly from the patient about the difficulties they face when approaching IC?

A recent study seeks to remedy this neglect in research; it involved a total of 200 adults who had independently been performing IC for at least 6 months across the US.

A significant portion of patients with neurogenic bladder will develop lifelong dependence upon intermittent catheterization (IC) for emptying their bladder. They are often patients with neurogenic diagnoses, such as spinal cord injuries, multiple sclerosis (MS) and Parkinson’s disease.

Les mer

Hospitalizations drop by 20% after individuals start with Intermittent Catheterization

Publisert av Wellspect Norway, 15.apr.2022

Studies on intermittent catheterization (IC) with larger samples sizes are rare and this study provides real-world evidence on IC use, which may be used to derive recommendations for improvement of care. This is among the first publications of a 3-year observation period including time before and after initial IC.

Les mer

After a spinal cord injury, can we predict who will recover independent bowel management during the first year?

Publisert av Wellspect Norway, 08.mar.2022

Neurogenic bowel dysfunction (NBD) with symptoms of constipation and fecal incontinence is a common complication of traumatic spinal cord injury. In a new study, the aim was to identify factors that could predict the recovery of independent bowel function to assist clinicians in their prognosis of bowel function and to guide them to bowel management strategies useful for the patient.

Les mer

Emne: bowel dysfunction, bowel management, spinal cord injury (SCI)

Are clinicians delivering the best care for patients with bladder and bowel dysfunction? A recent study suggests otherwise

Publisert av Wellspect Norway, 18.feb.2022

People with neurogenic bladder and/or bowel dysfunction often suffer from highly individualized symptoms. It can be difficult to quantify change in an individual’s symptoms using standardized measurement tools, and points to the value of Patient—Centered Outcome Measures.

Les mer

ISCoS Webinar: Reflecting on the past, Planning for the future

Publisert av Wellspect Norway, 04.feb.2022

We are honoured to have been invited to join the International Spinal Cord Injury Society (ISCoS) in the second episode of their webinar series: 'SCI Care: What really matters'.

Les mer

Emne: ISCoS, spinal cord injury (SCI)